Shares of Aviva plc (LON:AV – Get Free Report) have earned an average recommendation of “Moderate Buy” from the eight ratings firms that are covering the firm, MarketBeat reports. One equities research analyst has rated the stock with a sell recommendation, two have given a hold recommendation and five have issued a buy recommendation on the company. The average 12-month price target among analysts that have issued a report on the stock in the last year is GBX 733.50.
AV has been the subject of a number of research analyst reports. Royal Bank Of Canada restated an “outperform” rating and set a GBX 780 price objective on shares of Aviva in a research report on Wednesday, July 29th. Berenberg Bank increased their price target on Aviva from GBX 800 to GBX 820 and gave the stock a “buy” rating in a report on Monday. JPMorgan Chase & Co. lifted their target price on Aviva from GBX 715 to GBX 800 and gave the company an “overweight” rating in a research report on Thursday, August 13th. Jefferies Financial Group restated a “hold” rating and set a GBX 637 target price on shares of Aviva in a research note on Friday, May 15th. Finally, UBS Group reiterated a “buy” rating and set a GBX 750 price target on shares of Aviva in a research note on Monday, May 11th.
Get Our Latest Stock Analysis on Aviva
Aviva Price Performance
Insider Buying and Selling at Aviva
In other news, insider Pippa Lambert acquired 226 shares of the stock in a transaction that occurred on Wednesday, July 15th. The shares were purchased at an average cost of GBX 662 per share, for a total transaction of £1,496.12. Company insiders own 0.17% of the company’s stock.
Aviva Company Profile
Aviva plc provides various insurance, retirement, investment, and savings products in the United Kingdom, Ireland, Canada, and internationally. The company offers life insurance, long-term health and accident insurance, savings, pension, and annuity products, as well as pension fund business and lifetime mortgage products. It also provides insurance cover to individuals, small and medium-sized businesses for risks associated with motor vehicles and medical expenses, as well as property and liability, such as employers' and professional indemnity liabilities.
Further Reading
- Five stocks we like better than Aviva
- Commodities Are Booming, But These 3 ETFs Tell Different Stories
- 3 Active ETFs Making Big Moves in August
- This ETF Is Outperforming by Avoiding the S&P 500’s Biggest Problem
- Birkenstock Beats the Skeptics—But Not on EPS
Receive News & Ratings for Aviva Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aviva and related companies with MarketBeat.com's FREE daily email newsletter.
